booksshare.net -> -> -> .. -> " - " -> 74

- - ..

.., .. - .: , 2002. 182 c.
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 68 69 70 71 72 73 < 74 > 75 76 77 78 79 80 .. 345 >>

D: Reducdyn® (Nordmark)-Komb. Thioxidrene® (Bottu)
F: Thioncycline® (Merrell)-Komb. 1: Citiolase® (Roussel Maestretti)
Citrullin 372-75-8 Lebertherapeuticum
70796-17-7 Malat
ornithine, A^-carbamovl-, (l-)
216 С Citruilin - Clemastin
HN
I
C-NH-(CH2)3“CH-COOH • HCI
1 NaOH
2 CuO 3. H2S
04
ч nh2
v\ I
C- NH- (СНг1з- CH - COOH
I-Arginin-Hydrochlorid
Citruilin
2 durch Fermentation
a von Saccharomyces genus b aus Ornithin с von Arthrobacter
DOT 15,169(1979).
1 S. W. Fox, J. Biol. Chem. 123,687 (1938).
2 a JP 5 2143288 (Kyowa; Anm. 20.5.1976). b JP 5 0148 588 (Miura; Anm. 23.5.1974).
с JP 5 3075 387 (Kyowa; Anm. 13.12.1976). Weitere Verfahren:
JP 12248/67 (Ajinomoto; Anm. 11.9.1965).
JP 11758/68 (Kyowa; Anm. 15.11.1965).
S. W. Fox et al., J. Org. Chem. 6,410 (1941). Kristallisation:
JP 7 100174 (Ajinomoto; Anm. 20.11.1968). Isolierung aus Citrullus vulgaris Schrad.:
M. Wada, Biochem. Z. 224,420 (1930).
Anwendung als Lebertherapeuticum:
FP-M4182 (Inst, de Recherche Sri.; Anm. 9.3.1965). FP-M 5594 (Dimaphar; Anm. 1.7.1966).
FP-M 5703 (Lab. Carriere Carron; Anm. 30.8.1965). FP-M6305 (Dimaphar; Anm. 15.12.1966). Anwendung als Cholagogum:
FP-M 5695 (Lab. Carriere Carron; Anm. 29.8.1966). Citrullin-fumarat;
FP-M 6306 (Dimaphar; Anm. 15 .12.1966). Citrullin-maleat:
FP-M 6443 (Dimaphar; Anm. 21.4.1967).
D: Polilevo® (Spitzner)-Komb.
(+)-2-[2-[(/>-chloro-a-methyl-a-phenylbenzyl)oxy]-ethyl]-l-methylpyrrolidine
Clemastin
(Meclastin)
15686-51-8 14976-57-9 Hydrogenfumarat
Antiallergicum; Antihlstaminicum
a
4-Chlorbenzo-
phenon
Methyl-
magnesium-
chlorid
1-|4-Chtorphenyt)-1- phenylethanol
Clemastin - Clemizol С 217
н3с
Н’Я _ ?н3 '
NaNH2 / CI-CH2-CHW J
Natrium- / 2-{2-Chlorethyll-amid 1 - methyl вуг roll-
c-Q-i-o -CH2-CH2-<^]
:-o-<' * o-
^-Chloracetophe-
non
MgSr
Brombenzol bzw. Phenyl-magnesium-bromid
>-o-
CH3
C-OH
6
H3C
NaNH; / Cl-CH2-CH2^^]
Natrium - / Z-l 2-CMorethyi)-amid 1-methylpyrroli-
l-(A-Chlorphenyl)-
1-phenylethanol
GB-P 942 152 (Sandoz; Anm. 14.12.1960; CH-Prior. 19.1.1960, 3.8.1960, 27.9.1960). FP-M 1313 (Sandoz; Anm. 13.7.1961).
D: Tavegil® (Sandoz)
F: Tavegil (Sandoz)
GB: T avegil® (Sandoz)
I: Tavegil® (Wander)
J: Alagyi® (Sawai)
Alusas® (Fuso)
Anhistan® (Nippon Zoid) Antriptin® (Nippon Yakuhin) Batomu® (Zensei)
Benanzyl® (Isei)
Chlonaryl® (Ohta)
Clemanyl® (Kyoritsu Yamagata) Clemastine Fumarate (Showa) Fuluminol® (Tatsumi) Fumalestine® (Hishiyama) Furnartin® (Torii)
Histamedine® (Mohan) Inbestan® (Maruko)
Kinotomin® (Toa Eiyo) Lacretin® (Tokyo Tanabe) Lecasol® (Kaken)
Maikohis® (Nihon Yakukin) Mallermin-F® (Taiyo Yakuko) Marsthine® (Towa)
Masletene® (Shioe)
Natarilon® (Nippon Chemiphar) Piloral® (Nippon Kayaku) Raseitin® (Maruishi)
Reconin® (Toyama)
Romien® (Fuji Zoki)
Tavegyl® (Sandoz Sankyo) Telgin G® (Takata)
Trabest® (Hoei)
Xoiamin® (Sanko)
USA: Tavist® (Dorsey)
Clemizol
442-52-4
1163-36-6
Hydrochlorid
Antihistaminicum;
Antiallergicum
l-ro-chlorobenzyl-2-f 1 -pyrrolidinylmethyDbcnzimidazole
,no2
l[ + h2n-ch2
Cl
2-Chlor-
l-nitro-
benzoi
-O'
4-Chlorbenzylamin
N02
NH
218 С Clemizol - Clenbuterol
МИг r^VNH2
1... Cl—СО—CH2—Cl l^X..^C0-CH2-CI H0
NH ___________^ 'n'
ch2-
г.—л Chloracetylchlond | r. ry
СНг-
сНг-N^J
.-о»
USP 2689 853 (Schering AG; ert. 1954; D-Prior. 1950). Alternativ-Synthesen: DBP 980 644 (Schering AG; Anm. 1950). DBP 901649 (Schering AG; Anm. 1951).
TJltralan® (SEPPS)-Komb. Ultraproct® (SEPPS)-Komb. Penargyl® (Morgan)
Zahlr. Komb.-Prap.
Clenbuterol 37148-27-9 Broncholyticum
D: Megacillin® (Griinenthai)-Komb. mit Penicillin PreveciUin®(Griinenthal)-Komb. mit Penicillin F: Bellocilline® (Roger BeIlon)-Komb. I:
mit Penicillin
Deliproct® (SEPPS)-Komb.
4-amino-a-[(rerr-butylarnino)rnethyl]-3,5-dichlorobenzyl alcohol
°2NM0^c_ch3 Jo. o^^Q^c-снг-Вг • o2NH0bc-CH2-NH-cKH3i3
o 0 annin 0
4-Nitroacetophenon u>-Brom-£-nitroacetophenon
H;/Raney-Ni
H2N—^ ^—С — CH2 — NH — С[СНз)з —----HjN С — CH2 — NH — С(СНз)з
NaBH4
Cl \
H2N 1 -0 X 1 0 X 4 z X 1 0 0 1
r-' OH
Cl
Clenbuterol
<Q>-CH-CH2-NH-C(CH3)3 02N-^^)~CH-CH2-NH-C(CH3)3
OH
2-ferf-Butylammo-l-phenyl-ethanol
Clenbuterol - Clidinium-bromid С 219
,С(СНз1з
Н? /Raney- N1
h2n
-cxx
С(СНз)з
HjN-
CfCH3)3
Clenbuterot
5-(4-Агт1|ПО-3,5-(11сЫог phenyl }-3-ferf-butyl-2-oxazolidon
DOF1,221 (1976); 2,348 (1977).
DOT 14,59 (1978).
J. Keck et al., Arzneim.-Forsch. 22, 861 (1972). a DOS 1 793 416 (Thomae; Anm. 5.9.1967).
Belg-P 704213 (Thomae; Anm. 22.9.1967; D-Prior. 22.9.1966, 15.2.1967, 2.6.1967).
USP 3 536 712 (Boehringer Ing.; ert. 27.10.1970; D-Prior. 22.9.1966,15.2.1967, 2.6.1967). b DOS 2 157 040 (Thomae; Anm. 17.11.1971).
DBP 1 543 928 (Thomae; Anm. 22.9.1966).
Weitere Verfahren:
DAS 2 354959 (Thomae; Anm. 2.11.1973).
D: Spiropent® (Thomae)
Clidinium-bromid
3485-62-9
Ant i ch ol i nergicu m
<< 1 .. 68 69 70 71 72 73 < 74 > 75 76 77 78 79 80 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed